|
|
Preparation of genetically manipulated producers of hybrid manumycins
Krýslová, Dita ; Petříčková, Kateřina (advisor) ; Doubravová, Linda (referee)
Streptomyces are one of the most prolific producers of various secondary metabolites. Manumycin antibiotics represent an important class of these compounds. They belong to a big class of polyketide metabolites. While their antibiotic effect is not very significant, their other biological properties have a big potential in the treatment of inflammations, tumors, etc. They are characterized by two short polyketide chains, which are attached to a central subunit. At the end of the lower polyketide chain, a C5N cyclic unit is frequently attached. This thesis originates from the colabomycin E, an antibiotic, which was discovered by our team. This antibiotic is a new member of manumycin-type metabolites and is produced by Streptomyces aureus SOK1/5-04 strain. Previous studies on the function of individual genes in the biosynthetic gene cluster of colabomycin E inspired us to consider editing of the current biological activity of colabomycin E by replacement of the C5N unit with another, structurally similar bioactive subunit. Due to high structural similarity, we have selected 4,7- dihydroxycoumarin unit of novobiocin, an aminocoumarin-type metabolite produced also by Streptomyces. The 4,7-dihydroxycoumarin unit is pharmacophore with a cancerostatic activity. We expected that the cancerostatic activity...
|
|
|
Identification and activation of a cryptic biosynthetic gene cluster for manumycin-type metabolites in Saccharothrix espanaensis DSM44229
Zelenka, Tomáš ; Petříčková, Kateřina (advisor) ; Beranová, Jana (referee)
1 Abstract: Secondary metabolism of Gram-positive soil bacteria from the genus Streptomyces is a inestimable source of natural products including manumycins, which belong to a polyketide group. These products possess weak antimicrobial, but important antiinflammatory, and antitumor activities. Streptomyces sp. offers broad amounts of yet undiscovered antibiotics, potentially utilizable in clinical medicine. This fact makes out of these organisms a promising solution to our present problem with rising antibiotic resistance among microorganisms. Two main ways are applied in this research: There are efforts of prepairing new derivates based on known products and creating various modifications in their structure. Next, new producers are discovered by "genome mining" methods, activation of silent gene clusters, followed by improvements of antibiotic production. One of those silent clusters was found in the Saccharothrix espanaensis DSM44229 strain. The genetic information has been transferred to a heterologous host in order to characterize its product. Cluster activation and production of novel manumycin-type metabolites occurred in the host after the transfer.
|
guest ::
